SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.944    0.00 (0.00%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Transaction in Own Shares

3 Apr 2025 18:15

RNS Number : 6160D
BioPharma Credit PLC
03 April 2025
 

BioPharma Credit plc

(the "Company")

TRANSACTION IN OWN SHARES

 

BioPharma Credit PLC announces that today it has purchased the following number of its ordinary shares of US $0.01 each through J.P. Morgan Securities plc into treasury.

 

 

Ordinary Shares: BPCR LN

Date of purchase: 3 April 2025

Number of ordinary shares purchased: 500,000

Lowest price per share: $0.8700

Highest price per share: $0.8700

Trading venue: JPMSI

 

 

Ordinary Shares: BPCR LN

Date of purchase: 3 April 2025

Number of ordinary shares purchased: 50,000

Lowest price per share: $0.8700

Highest price per share: $0.8700

Trading venue: LSE

 

 

Aggregate volume per date per trading venue: 550,000

Weighted average price per day per trading venue: $0.8737

 

Following the above transaction, the Company holds 244,207,072 of its ordinary shares in treasury and has 1,129,724,995 ordinary shares in issue (excluding treasury shares). Therefore, the total number of voting rights in the Company is 1,129,724,995. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

Enquiries:

BioPharma Credit plc

via MUFG Corporate Governance Limited

Company Secretary

+44 (0) 333 300 1932

Burson Buchanan

Mark Court / Jamie Hooper / Henry Wilson / Samuel Adams

+44 (0)20 7466 5000

biopharmacredit@buchanan.uk.com

 

Notes to Editors:

 

BioPharma Credit PLC is London's only specialist debt investor to the life sciences industry and joined the LSE in March 2017. BioPharma Credit PLC seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. BioPharma Credit PLC seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

 

 

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQXLFBEZLLBBE
Date   Source Headline
31st Dec 202012:00 pmRNSDirector/PDMR Shareholding
21st Dec 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Nov 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
12th Nov 20207:00 amRNSDividend Declaration
9th Nov 20207:00 amRNSADDITIONAL INVESTMENT IN EPIZYME
21st Oct 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
13th Oct 20203:30 pmRNSHolding(s) in Company
8th Oct 20202:00 pmRNSHolding(s) in Company
1st Oct 20204:45 pmRNSDirector/PDMR Shareholding
1st Oct 202011:00 amRNSDirector/PDMR Shareholding
1st Oct 202011:00 amRNSDirector/PDMR Shareholding
28th Sep 20207:00 amRNSSTATEMENT REGARDING SAREPTA THERAPEUTICS
21st Sep 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
16th Sep 20207:05 amRNSAppointment of New Director
16th Sep 20207:00 amRNSHalf-year Report
9th Sep 20204:00 pmRNSLEXICON PHARMACEUTICALS PREPAYMENT
21st Aug 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Aug 20203:25 pmRNSNotice of Half Year Results
12th Aug 20203:30 pmRNSDividend Declaration
7th Aug 20207:00 amRNSUPDATES TO THE PORTFOLIO
4th Aug 20204:30 pmRNSHolding(s) in Company
4th Aug 202011:15 amRNSHolding(s) in Company
3rd Aug 20201:15 pmRNSTotal Voting Rights
30th Jul 20204:00 pmRNSSTATEMENT REGARDING LEXICON PHARMACEUTICALS
24th Jul 20203:15 pmRNSHolding(s) in Company
21st Jul 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Jul 20207:00 amRNSAMICUS PREPAYMENT
16th Jul 20207:00 amRNSCOMPLETION OF SHARE BUYBACK PROGRAMME
15th Jul 20205:30 pmRNSTransaction in Own Shares
14th Jul 20205:30 pmRNSTransaction in Own Shares
13th Jul 20205:45 pmRNSTransaction in Own Shares
13th Jul 20207:00 amRNSSHARE BUY-BACK PROGRAMME
9th Jul 20205:45 pmRNSDirector/PDMR Shareholding
25th Jun 20203:00 pmRNSResult of AGM
22nd Jun 20207:00 amRNSNet Asset Value(s) and Monthly Factsheet
22nd Jun 20207:00 amRNSActivation of Discount Control Mechanism
19th Jun 20204:30 pmRNSChange of AGM Venue
29th May 20205:30 pmRNSNotice of AGM
28th May 20205:30 pmRNSHolding(s) in Company
26th May 20207:00 amRNSNEW CREDIT FACILITY
22nd May 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
14th May 20203:00 pmRNSDividend Declaration
7th May 20205:30 pmRNSDate of Annual General Meeting
27th Apr 202012:30 pmRNSArticles of Association
23rd Apr 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Apr 202012:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20205:40 pmRNSHolding(s) in Company
20th Mar 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Mar 20202:00 pmRNSREPLACEMENT: Annual Financial Report
10th Mar 20207:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.